liptruzet
(DTZNNABBRQKSGZ-PZEZLDPLSA-L)
Structure
- SMILES
- O[C@@H](C[C@H](CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1.O[C@@H](C[C@H](CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1.Oc1ccc(cc1)[C@@H]1[C@@H](CC[C@@H](c2ccc(cc2)F)O)C(=O)N1c1ccc(cc1)F.[Ca+2]
- Molecular Formula:
- C90H89CaF4N5O13
- Molecular Weight:
- 1564.770
- Log P:
- 15.0571
- Hydrogen Bond Acceptor:
- 18
- Hydrogen Bond Donor:
- 8
- TPSA:
- 290.01
- CAS Number(s):
- 1001913-42-3
Synonym(s)
1.
liptruzet
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Myalgia | FAERS: 16 | US FAERS | |
| 2 | Blood creatine phosphokinase increased | FAERS: 5 | US FAERS | |
| 3 | Drug dose omission | FAERS: 5 | US FAERS | |
| 4 | Fatigue | FAERS: 4 | US FAERS | |
| 5 | Nausea | FAERS: 4 | US FAERS | |
| 6 | Transaminases increased | FAERS: 4 | US FAERS | |
| 7 | Ageusia | FAERS: 3 | US FAERS | |
| 8 | Asthenia | FAERS: 3 | US FAERS | |
| 9 | No adverse event | FAERS: 3 | US FAERS | |
| 10 | Tinnitus | FAERS: 3 | US FAERS | |
| 11 | Vomiting | FAERS: 3 | US FAERS | |
| 12 | Abdominal Pain | FAERS: 2 | US FAERS | |
| 13 | Blood cholesterol increased | FAERS: 2 | US FAERS | |
| 14 | Dysgeusia | FAERS: 2 | US FAERS | |
| 15 | Headache | FAERS: 2 | US FAERS | |
| 16 | Malaise | FAERS: 2 | US FAERS | |
| 17 | Medication Error | FAERS: 2 | US FAERS | |
| 18 | Pain | FAERS: 2 | US FAERS | |
| 19 | Pyelonephritis | FAERS: 2 | US FAERS | |
| 20 | Swelling | FAERS: 2 | US FAERS | |
| 21 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 22 | Adverse event | FAERS: 1 | US FAERS | |
| 23 | Alopecia | FAERS: 1 | US FAERS | |
| 24 | Anorgasmia | FAERS: 1 | US FAERS | |
| 25 | Arthralgia | FAERS: 1 | US FAERS | |
| 26 | Autoimmune hepatitis | FAERS: 1 | US FAERS | |
| 27 | Blood creatine phosphokinase | FAERS: 1 | US FAERS | |
| 28 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 29 | Cell Death | FAERS: 1 | US FAERS | |
| 30 | Cerebrovascular accident | FAERS: 1 | US FAERS | |
| 31 | Cholelithiasis | FAERS: 1 | US FAERS | |
| 32 | Cholestasis | FAERS: 1 | US FAERS | |
| 33 | Chromatopsia | FAERS: 1 | US FAERS | |
| 34 | Constipation | FAERS: 1 | US FAERS | |
| 35 | Depressed mood | FAERS: 1 | US FAERS | |
| 36 | Dizziness | FAERS: 1 | US FAERS | |
| 37 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 38 | Erythema | FAERS: 1 | US FAERS | |
| 39 | Exposure to toxic agent | FAERS: 1 | US FAERS | |
| 40 | Feeling jittery | FAERS: 1 | US FAERS | |
| 41 | Flank Pain | FAERS: 1 | US FAERS | |
| 42 | Flatulence | FAERS: 1 | US FAERS | |
| 43 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 44 | Incorrect route of product administration | FAERS: 1 | US FAERS | |
| 45 | Muscle enzyme increased | FAERS: 1 | US FAERS | |
| 46 | Muscle tightness | FAERS: 1 | US FAERS | |
| 47 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 48 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 49 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 50 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 51 | Myositis | FAERS: 1 | US FAERS | |
| 52 | Myotonia | FAERS: 1 | US FAERS | |
| 53 | Panic Disorder | FAERS: 1 | US FAERS | |
| 54 | Polyneuropathy | FAERS: 1 | US FAERS | |
| 55 | Prerenal failure | FAERS: 1 | US FAERS | |
| 56 | Product blister packaging issue | FAERS: 1 | US FAERS | |
| 57 | Product packaging issue | FAERS: 1 | US FAERS | |
| 58 | Product quality issue | FAERS: 1 | US FAERS | |
| 59 | Product supply issue | FAERS: 1 | US FAERS | |
| 60 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 61 | Septic Shock | FAERS: 1 | US FAERS | |
| 62 | Stress | FAERS: 1 | US FAERS | |
| 63 | Urinary Retention | FAERS: 1 | US FAERS | |
| 64 | Urinary tract infection | FAERS: 1 | US FAERS | |
| 65 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 66 | muscle injury | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.